What’s Next For ChemoCentryx Stock After Over A 100% Rise In A Month?
Logo
Marketwires
The stock price of ChemoCentryx (NASDAQ: CCXI), a biopharmaceuticals company focused on orally-administered therapeutics to treat autoimmune diseases and inflammatory disorders, has skyrocketed with a 104% rise over the last month. This…
